Press Releases

A new chapter in hepatitis B treatment. If successful, TherVacB could represent a breakthrough in the treatment of chronic hepatitis B.

Domein: dzif.de Bekijk meer

Elebsiran is an investigational hepatitis B virus-targeting small interfering ribonucleic acid (siRNA) discovered by Alnylam Pharmaceuticals. It ...

Domein: contagionlive.com Bekijk meer

Researchers Eye 'Functional Cure' for Hep B by Adding to Drug Combo Arsenal. Hepatitis B virus, a killer of more than one million people ...

Domein: slu.edu Bekijk meer

Hepalatide, used with pegylated interferon-alpha, shows promise for curing chronic hepatitis B by eliminating cccDNA from liver cells.

Domein: fehv.org Bekijk meer

PBGENE-HBV is the first-ever investigational in vivo gene editing therapy cleared to enter clinical trials for the treatment of chronic hepatitis B in the ...

Domein: investor.precisionbiosciences.com Bekijk meer

by P Korkmaz · 2023 · Cited by 6 — Today, pegylated interferon (Peg-IFN) and nucleos(t)ide analogs (NAs) are used in the treatment of patients with chronic hepatitis B (CHB). ...

Domein: pubmed.ncbi.nlm.nih.gov Bekijk meer

Disrupting this process in an infection could be a new way of treating the deadly disease, new research suggests.

Domein: mskcc.org Bekijk meer

Research project to cure Hepatitis B patients under the European Horizon 2020 programme using a newly designed vaccine in a clinical trial starting in ...

Domein: thervacb.eu Bekijk meer

PBGENE-HBV is designed to eliminate cccDNA and inactivate integrated HBV DNA that current treatments cannot effectively address. By: Karen O'Hanlon Cohrt - Mar.

Domein: crisprmedicinenews.com Bekijk meer